Abiopharma

Discovr Radio to Embed Across All Four Days of CAMP Toronto in First Major Activation with Beatcave

Castle Biosciences TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barretts Esophagus

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

Aya Gold & Silver Added to the VanEck Gold Miners ETF (GDX)

HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

Mobileye To Establish Vertically Integrated Robotaxi Business

Cipher Digital Announces Appointment of Bill Blevins as Head of Grid Strategies

VitalHub Announces Deployments of Referral Management Solutions

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer